Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA-assisted COPE for PTSD and AUD
NCT05709353Phase 2Recruiting
- Sponsor
- University of Sydney
- Start
- Sep 2023
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of midomafetamine in post-traumatic stress disorder (PTSD), alcohol use disorder (AUD), sponsored by University of Sydney. Started Sep 2023; status: recruiting.
02
Drugs
midomafetamine
03
Conditions
post-traumatic stress disorder (PTSD)alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT05709353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05709353.